Medicare Enrolled

Dr. Mikel Muse, DO

MOHS-Micrographic Surgery Physician · Vancouver, WA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
2415 NE 134TH ST STE 107, Vancouver, WA 98686
9719158573
In practice since 2019 (7 years)
NPI: 1639639339 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Muse from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Muse? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Muse

Dr. Mikel Muse is a mohs-micrographic surgery physician in Vancouver, WA, with 7 years of NPI registration. Based on federal Medicare data, Dr. Muse performed 489 Medicare services across 337 unique beneficiaries.

Between the years covered by Open Payments, Dr. Muse received a total of $4,840 from 22 pharmaceutical and/or device companies across 120 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in mohs-micrographic surgery physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Muse is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 7 years in practice ▲ 489 Medicare services $4,840 industry payments

Medicare Practice Summary

Medicare Utilization ↗
489
Medicare services
Bottom 15% in WA for mohs-micrographic surgery physician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
337
Unique beneficiaries
$37
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~70 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
185 $5 $10
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
73 $34 $105
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
59 $72 $157
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
59 $66 $137
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
37 $77 $176
Additional skin growth biopsy
Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session.
24 $37 $81
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
21 $41 $87
New patient office visit, 15-29 minutes
An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold.
18 $51 $108
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
13 $85 $170
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,840
Total received (2021-2024)
Avg $1,210/year across 4 years
Top 8% in WA for mohs-micrographic surgery physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
22
Companies
120
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,840 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,331
2023
$1,742
2022
$695
2021
$72

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$522
ABBVIE INC.
$367
Dermavant Sciences, Inc.
$357
LEO Pharma Inc.
$249
SUN PHARMACEUTICAL INDUSTRIES INC.
$206
GENZYME CORPORATION
$158
E.R. Squibb & Sons, L.L.C.
$156
Regeneron Pharmaceuticals, Inc.
$72
Lilly USA, LLC
$66
Regeneron Healthcare Solutions, Inc.
$66
Boehringer Ingelheim Pharmaceuticals, Inc.
$28
UCB, Inc.
$24
Verrica Pharmaceuticals Inc.
$17
Amgen Inc.
$16
Incyte Corporation
$15
Galderma Laboratories, L.P.
$14
Top 3 companies account for 53.4% of 2024 payments
All-time payments by company (2021-2024) ›
ABBVIE INC.
$703
Janssen Biotech, Inc.
$559
Dermavant Sciences, Inc.
$524
LEO Pharma Inc.
$500
AbbVie Inc.
$450
E.R. Squibb & Sons, L.L.C.
$312
Lilly USA, LLC
$272
UCB, Inc.
$271
GENZYME CORPORATION
$222
SUN PHARMACEUTICAL INDUSTRIES INC.
$206
PFIZER INC.
$201
Novartis Pharmaceuticals Corporation
$128
Arcutis Biotherapeutics, Inc.
$108
Regeneron Healthcare Solutions, Inc.
$102
Regeneron Pharmaceuticals, Inc.
$72
Boehringer Ingelheim Pharmaceuticals, Inc.
$66
Sun Pharmaceutical Industries Inc.
$51
Ortho Dermatologics, a division of Bausch Health US, LLC
$31
Verrica Pharmaceuticals Inc.
$17
Amgen Inc.
$16
Incyte Corporation
$15
Galderma Laboratories, L.P.
$14
Top 3 companies account for 36.9% of all-time payments
Associated products mentioned in payments ›
ADBRY · Absorica LD · BLU-U · Bimzelx · COSENTYX · DUPIXENT · EUCRISA · HUMIRA · ILUMYA · LIBTAYO · OLUMIANT · OPZELURA · Odomzo · Otezla · RINVOQ · SILIQ · SKYRIZI · SPEVIGO · Sotyktu · TALTZ · TREMFYA · VTAMA · Winlevi · YCANTH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for mohs-micrographic surgery physician in WA.

Looking for a mohs-micrographic surgery physician in Vancouver?
Compare mohs-micrographic surgery physicians in the Vancouver area by procedure volume, costs, and industry payment transparency.
Browse mohs-micrographic surgery physicians nearby

Geographic Context

Mohs-micrographic surgery physicians within 10 mi
7
Per 100K population
1.4
County median income
$94,948
Nearest hospital
LEGACY SALMON CREEK MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Muse is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 8% of WA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Muse experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Muse performed 185 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Muse receive payments from pharmaceutical companies?
Yes. Dr. Muse received a total of $4,840 from 22 companies across 120 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Muse's costs compare to other mohs-micrographic surgery physicians in Vancouver?
Dr. Muse's average Medicare payment per service is $37. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Muse) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →